Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI) . It binds to and potentiates the action of antithrombin, and inhibits coagulation factors XIa, IXa, Xa and IIa (thrombin), thereby preventing formation of blood clots.
Product Specifications
CAS Number
679809-58-6
Purity
>98% (HPLC)
Solubility
In Vitro: H2O : ≥ 100 mg/mL
Smiles
[Na+].[Na+].[Na+].[Na+].C[C@@H]1[C@@H] (NC (C) =O) [C@@H] (OC2[C@H] (O) [C@@H] (O) [C@H] (OC3[C@H]4CO[C@H] (O4) [C@H] (NS ([O-]) (=O) =O) [C@H]3O) OC2C ([O-]) =O) O[C@H] (CO) [C@H]1O[C@@H]1CC ([C@@H] (O[C@H]2O[C@H] (COS (O) (=O) =O) [C@@H] (O[C@@H]3OC (=C[C@H] (O) [C@H]3O) C ([O-]) =O) [C@H] (
Molecular Formula
C42H59N3Na4O35S2
Molecular Weight
1322
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
